← Back to Conditions

Myeloproliferative disorder

disorder
SNOMED 425333006CUI C0027022

Overview

Source: MedlinePlus.gov, National Library of Medicine. Not a substitute for medical advice.

Treatments & Interventions

Research Evidence

Peer-reviewed studies linked via MeSH term "Disorders, Myeloproliferative" from the MEDLINE/PubMed database.

Sort:
The Pitfalls of Global Hemostasis Assays in Myeloproliferative Neoplasms and Future Challenges.
[object Object], [object Object], [object Object] · Semin Thromb Hemost · 2024
PMID: 37068511Meta-Analysis
Anticoagulation for splanchnic vein thrombosis in myeloproliferative neoplasms: a systematic review and meta-analysis.
[object Object], [object Object], [object Object] et al. · J Thromb Haemost · 2024
PMID: 39127323Meta-Analysis
The role of clonal progression leading to the development of therapy-related myeloid neoplasms.
[object Object], [object Object], [object Object] et al. · Ann Hematol · 2024
PMID: 39031199Meta-AnalysisFull text (PMC)
CSF3R-mutant chronic myelomonocytic leukemia is a distinct clinically subset with abysmal prognosis: a case report and systematic review of the literature.
[object Object], [object Object], [object Object] et al. · Leuk Lymphoma · 2023
PMID: 37395413Meta-Analysis
Current evidence on the use of direct oral anticoagulants in patients with myeloproliferative neoplasm: a systematic review.
[object Object], [object Object], [object Object] · Expert Rev Hematol · 2023
PMID: 36709432Meta-Analysis
Androgen use in bone marrow failures and myeloid neoplasms: Mechanisms of action and a systematic review of clinical data.
[object Object], [object Object], [object Object] et al. · Blood Rev · 2023
PMID: 37709654Meta-Analysis
Myasthenia Gravis and Myeloproliferative Neoplasms - Mere Association or Paraneoplastic Neurologic Syndrome: A Mini-Review.
[object Object], [object Object], [object Object] et al. · Acta Biomed · 2022
PMID: 35075066Meta-AnalysisFull text (PMC)
Management of Myeloproliferative Neoplasms (MPNs).
[object Object], [object Object] · J Oncol Pharm Pract · 2022
PMID: 35296179Meta-Analysis

Quick Facts

SNOMED CT
425333006
UMLS CUI
C0027022
Fully Specified Name
Myeloproliferative disorder (disorder)
Specialists
0
Diagnostic Biomarkers
0
Known Treatments
1
Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.